10.1      Bylaws (Statuts) of Sanofi Pharma Bristol-Myers Squibb, a partnership
          (societe en nom collectif) organized under French law, dated as of
          June 6, 1997. English Translation.

10.2      Internal Regulation (Reglement Interieur) of Sanofi Pharma Bristol-Myers
          Squibb dated as of June 6, 1997 and effective as of January 1, 1997.
          English Translation. †

10.3      Partnership Agreement of Bristol-Myers Squibb Sanofi Pharmaceuticals
          Holding Partnership between Sanofi Pharmaceuticals, Inc. and
          Bristol-Myers Squibb Company Investco, Inc. dated as of January 1, 1997.
          †

10.4      Territory A Alliance Support Agreement between Sanofi and Bristol-Myers
          Squibb Company dated as of January 1, 1997. †

10.5      Amendment No. 1 to the Territory A Alliance Support Agreement between
          Sanofi-Synthelabo and Bristol-Myers Squibb Company dated as of October
          17, 2001. †

10.6      Territory B Alliance Support Agreement between Sanofi and Bristol-Myers
          Squibb Company dated as of January 1, 1997. †

10.7      Amendment No. 1 to the Territory B Alliance Support Agreement between
          Sanofi-Synthelabo and Bristol-Myers Squibb Company dated as of October
          17, 2001. †

10.8      Clopidogrel Intellectual Property License and Supply Agreement between
          Sanofi and Sanofi Pharma Bristol-Myers Squibb dated as of January 1,
          1997. †

10.9      Clopidogrel Intellectual Property License and Supply Agreement between
          Sanofi and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding
          Partnership dated as of January 1, 1997. †

10.10     Product Know-How License Agreement among Sanofi, Bristol-Myers Squibb
          Company and Sanofi Pharma Bristol-Myers Squibb dated as of January 1,
          1997. †


--------------------------------------------------------------------------------
10.11    Product Know-How License Agreement among Sanofi, Bristol-Myers Squibb
         Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding
         Partnership dated as of January 1, 1997. †

10.12    Restated Development and Commercialization Collaboration Agreement
         between Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company
         dated as of October 23, 2001. †

10.13    Amendment No. 3 to the Restated Development and Commercialization
         Collaboration Agreement between Otsuka Pharmaceutical Co., Ltd. and
         Bristol-Myers Squibb Company dated as of September 25, 2006. †

10.14    Amendment No. 5 to the Restated Development and Commercialization
         Collaboration Agreement between Otsuka Pharmaceutical Co., Ltd. and
         Bristol-Myers Squibb Company effective as of April 4, 2009. †